Christy Ballantyne

Houston, USA


Tuesday 28 May 15:45

Remant TRL and atherosclerosis

Apo B containing Lipoproteins in ATH


Monday 30 November 00:00

Dyslipidaemia guidelines: What is new?

Dyslipidaemia guidelines: What is new?


Sunday 26 May 16:00

Optimal lipid lowering therapy: New and established therapies

How can we improve outcomes in our patients with CAD?


Tuesday 28 May 12:30

REDUCE-IT: an in depth analysis

The Omega-3 tale: Where do we stand?


Tuesday 28 May 14:00

Clinical experience with Bempedoic Acid

New approaches to LDL lowering


Monday 27 May 15:45

EFFICACY AND SAFETY OF BEMPEDOIC ACID + EZETIMIBE FIXED-DOSE COMBINATION IN PATIENTS AT HIGH CVD RISK AND WITH ELEVATED LDL-C RECEIVING MAXIMALLY TOLERATED STATIN THERAPY

Late Breaking session on pharmacology of dyslipidemia